Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

A survey of recipient client physician satisfaction with teleoncology services originating from thunder bay regional health sciences centre.

Brigden M, Minty A, Pilatzke S, Della Vidova L, Sherrington L, McPhail K.

Telemed J E Health. 2008 Apr;14(3):250-4. doi: 10.1089/tmj.2007.0048.

PMID:
18570548
2.

The occasional trigger point injection.

Minty R, Kelly L, Minty A.

Can J Rural Med. 2007 Fall;12(4):241-4. Review. No abstract available.

3.

End-of-life issues for aboriginal patients: a literature review.

Kelly L, Minty A.

Can Fam Physician. 2007 Sep;53(9):1459-65. Review.

4.

Single-dose intrathecal analgesia to control labour pain: is it a useful alternative to epidural analgesia?

Minty RG, Kelly L, Minty A, Hammett DC.

Can Fam Physician. 2007 Mar;53(3):437-42. Review.

5.

IL-13 acutely augments HIV-specific and recall responses from HIV-1-infected subjects in vitro by modulating monocytes.

Papasavvas E, Sun J, Luo Q, Moore EC, Thiel B, MacGregor RR, Minty A, Mounzer K, Kostman JR, Montaner LJ.

J Immunol. 2005 Oct 15;175(8):5532-40.

6.

IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells.

Laoukili J, Perret E, Willems T, Minty A, Parthoens E, Houcine O, Coste A, Jorissen M, Marano F, Caput D, Tournier F.

J Clin Invest. 2001 Dec;108(12):1817-24.

8.

Encapsulation in hollow fibres of xenogeneic cells engineered to secrete IL-4 or IL-13 ameliorates murine collagen-induced arthritis (CIA).

Bessis N, Honiger J, Damotte D, Minty A, Fournier C, Fradelizi D, Boissier M.

Clin Exp Immunol. 1999 Aug;117(2):376-82.

9.

Interleukin-13 prevents autoimmune diabetes in NOD mice.

Zaccone P, Phillips J, Conget I, Gomis R, Haskins K, Minty A, Bendtzen K, Cooke A, Nicoletti F.

Diabetes. 1999 Aug;48(8):1522-8.

PMID:
10426368
10.
11.

Administration of interleukin 13 to simian immunodeficiency virus-infected macaques: induction of intestinal epithelial atrophy.

Zou W, Coulomb A, Venet A, Foussat A, Berrebi D, Beyer C, Crevon MC, Minty A, Couedel-Courteille A, Vivier E, Capron F, Galanaud P, Emilie D.

AIDS Res Hum Retroviruses. 1998 Jun 10;14(9):775-83.

PMID:
9643377
12.

Regulation of interleukin-13 receptor constituents on mature human B lymphocytes.

Ogata H, Ford D, Kouttab N, King TC, Vita N, Minty A, Stoeckler J, Morgan D, Girasole C, Morgan JW, Maizel AL.

J Biol Chem. 1998 Apr 17;273(16):9864-71.

13.

Stable polarization of peripheral blood T cells towards type 1 or type 2 phenotype after polyclonal activation.

Asselin S, Conjeaud H, Minty A, Fradelizi D, Breban M.

Eur J Immunol. 1998 Feb;28(2):532-9.

14.

Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF-alpha)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13.

Bessis N, Chiocchia G, Kollias G, Minty A, Fournier C, Fradelizi D, Boissier MC.

Clin Exp Immunol. 1998 Feb;111(2):391-6. Erratum in: Clin Exp Immunol 1998 Jul;113(1):145.

15.

IL-13 induces CD34+ cells isolated from G-CSF mobilized blood to differentiate in vitro into potent antigen presenting cells.

Lopez M, Amorim L, Gane P, Cristoph A, Bardinet D, Abina AM, Minty A, Bernard J.

J Immunol Methods. 1997 Oct 27;208(2):117-29.

PMID:
9433467
16.

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.

Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D.

Cell. 1997 Aug 22;90(4):809-19.

17.

The related cytokines interleukin-13 and interleukin-4 are distinguished by differential production and differential effects on T lymphocytes.

Minty A, Asselin S, Bensussan A, Shire D, Vita N, Vyakarnam A, Wijdenes J, Ferrara P, Caput D.

Eur Cytokine Netw. 1997 Jun;8(2):203-13.

20.

Interleukin-8 production by the human colon epithelial cell line HT-29: modulation by interleukin-13.

Kolios G, Robertson DA, Jordan NJ, Minty A, Caput D, Ferrara P, Westwick J.

Br J Pharmacol. 1996 Sep;119(2):351-9.

21.

Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13.

Serve H, Oelmann E, Herweg A, Oberberg D, Serve S, Reufi B, Mücke C, Minty A, Thiel E, Berdel WE.

Cancer Res. 1996 Aug 1;56(15):3583-8.

22.

Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis.

Chaouchi N, Wallon C, Goujard C, Tertian G, Rudent A, Caput D, Ferrera P, Minty A, Vazquez A, Delfraissy JF.

Blood. 1996 Feb 1;87(3):1022-9.

23.

Interleukin-13 inhibits inducible nitric oxide synthase expression in human mesangial cells.

Saura M, Martínez-Dalmau R, Minty A, Pérez-Sala D, Lamas S.

Biochem J. 1996 Jan 15;313 ( Pt 2):641-6.

24.

The insulin receptor substrate-1-related 4PS substrate but not the interleukin-2R gamma chain is involved in interleukin-13-mediated signal transduction.

Wang LM, Michieli P, Lie WR, Liu F, Lee CC, Minty A, Sun XJ, Levine A, White MF, Pierce JH.

Blood. 1995 Dec 1;86(11):4218-27.

25.

Differential effects of recombinant human interleukin-13 on the in vitro growth of human haemopoietic progenitor cells.

Xi X, Schlegel N, Caen JP, Minty A, Fournier S, Caput D, Ferrara P, Han ZC.

Br J Haematol. 1995 Aug;90(4):921-7.

PMID:
7669673
26.

IL-13 supports differentiation of dendritic cells from circulating precursors in concert with GM-CSF.

Piemonti L, Bernasconi S, Luini W, Trobonjaca Z, Minty A, Allavena P, Mantovani A.

Eur Cytokine Netw. 1995 Jul-Dec;6(4):245-52.

PMID:
8789290
27.

Interleukin-13 selectively suppresses the growth of human macrophage progenitors at the late stage.

Sakamoto O, Hashiyama M, Minty A, Ando M, Suda T.

Blood. 1995 Jun 15;85(12):3487-93.

28.

Isolation of an IL-13-dependent subclone of the B9 cell line useful for the estimation of human IL-13 bioactivity.

Bouteiller CL, Astruc R, Minty A, Ferrara P, Lupker JH.

J Immunol Methods. 1995 Apr 12;181(1):29-36.

PMID:
7730664
29.

Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15.

Matthews DJ, Clark PA, Herbert J, Morgan G, Armitage RJ, Kinnon C, Minty A, Grabstein KH, Caput D, Ferrara P, et al.

Blood. 1995 Jan 1;85(1):38-42.

30.

Interleukin-13 gene expression by malignant and EBV-transformed human B lymphocytes.

Fior R, Vita N, Raphael M, Minty A, Maillot MC, Crevon MC, Caput D, Biberfeld P, Ferrara P, Galanaud P, et al.

Eur Cytokine Netw. 1994 Nov-Dec;5(6):593-600.

PMID:
7727691
31.

Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats.

Cash E, Minty A, Ferrara P, Caput D, Fradelizi D, Rott O.

J Immunol. 1994 Nov 1;153(9):4258-67.

PMID:
7523520
32.

Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production.

Sironi M, Sciacca FL, Matteucci C, Conni M, Vecchi A, Bernasconi S, Minty A, Caput D, Ferrara P, Colotta F, et al.

Blood. 1994 Sep 15;84(6):1913-21.

33.

IL-4 and IL-13 have overlapping but distinct effects on HIV production in monocytes.

Mikovits JA, Meyers AM, Ortaldo JR, Minty A, Caput D, Ferrara P, Ruscetti FW.

J Leukoc Biol. 1994 Sep;56(3):340-6.

PMID:
7916030
34.

Interleukin 13: novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells.

Jacobsen SE, Okkenhaug C, Veiby OP, Caput D, Ferrara P, Minty A.

J Exp Med. 1994 Jul 1;180(1):75-82.

35.

Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma.

Doyle AG, Herbein G, Montaner LJ, Minty AJ, Caput D, Ferrara P, Gordon S.

Eur J Immunol. 1994 Jun;24(6):1441-5.

PMID:
7911424
36.

Human interleukin-13 activates the interleukin-4-dependent transcription factor NF-IL4 sharing a DNA binding motif with an interferon-gamma-induced nuclear binding factor.

Köhler I, Alliger P, Minty A, Caput D, Ferrara P, Höll-Neugebauer B, Rank G, Rieber EP.

FEBS Lett. 1994 May 30;345(2-3):187-92.

37.

Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells.

Colotta F, Re F, Muzio M, Polentarutti N, Minty A, Caput D, Ferrara P, Mantovani A.

J Biol Chem. 1994 Apr 29;269(17):12403-6.

38.

Interleukin-13 stimulates interleukin-6 production by human keratinocytes. Similarity with interleukin-4.

Derocq JM, Segui M, Poinot-Chazel C, Minty A, Caput D, Ferrara P, Casellas P.

FEBS Lett. 1994 Apr 18;343(1):32-6.

39.
40.

Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine.

Dahinden CA, Geiser T, Brunner T, von Tscharner V, Caput D, Ferrara P, Minty A, Baggiolini M.

J Exp Med. 1994 Feb 1;179(2):751-6.

41.

Interleukin 13 is a B cell stimulating factor.

Defrance T, Carayon P, Billian G, Guillemot JC, Minty A, Caput D, Ferrara P.

J Exp Med. 1994 Jan 1;179(1):135-43.

42.

IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes.

Herbert JM, Savi P, Laplace MC, Lalé A, Dol F, Dumas A, Labit C, Minty A.

FEBS Lett. 1993 Aug 16;328(3):268-70.

43.

Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro.

Montaner LJ, Doyle AG, Collin M, Herbein G, Illei P, James W, Minty A, Caput D, Ferrara P, Gordon S.

J Exp Med. 1993 Aug 1;178(2):743-7.

44.

Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses.

Minty A, Chalon P, Derocq JM, Dumont X, Guillemot JC, Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B, et al.

Nature. 1993 Mar 18;362(6417):248-50.

PMID:
8096327
45.

Molecular cloning of the MCP-3 chemokine gene and regulation of its expression.

Minty A, Chalon P, Guillemot JC, Kaghad M, Liauzun P, Magazin M, Miloux B, Minty C, Ramond P, Vita N, et al.

Eur Cytokine Netw. 1993 Mar-Apr;4(2):99-110.

PMID:
8318676
47.

Stable expression and function of EBV/C3d receptor following genomic transfection into murine fibroblast L cells.

Cantaloube JF, Piechaczyk M, Calender A, Lenoir G, Minty A, Carrière D, Fischer E, Poncelet P.

Eur J Immunol. 1990 Feb;20(2):409-16.

PMID:
1690137
48.

Control of myogenesis in the mouse myogenic C2 cell line by medium composition and by insulin: characterization of permissive and inducible C2 myoblasts.

Pinset C, Montarras D, Chenevert J, Minty A, Barton P, Laurent C, Gros F.

Differentiation. 1988 Jun;38(1):28-34.

PMID:
3053306
49.

The 'CC.Ar.GG' box. A protein-binding site common to transcription-regulatory regions of the cardiac actin, c-fos and interleukin-2 receptor genes.

Phan-Dinh-Tuy F, Tuil D, Schweighoffer F, Pinset C, Kahn A, Minty A.

Eur J Biochem. 1988 May 2;173(3):507-15.

50.

In vivo system for characterizing clonal variation and tissue-specific gene regulatory factors based on function.

Hardeman EC, Minty A, Benton-Vosman P, Kedes L, Blau HM.

J Cell Biol. 1988 Apr;106(4):1027-34.

Supplemental Content

Support Center